文献速递消化道肿瘤与早癌

MET信号介导肠隐窝-绒毛发育、再生与腺瘤形成,并受干细胞CD44异构体促进

MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
PubMed 文献 · Gastroenterology · 2017-07-14

该研究利用肠类器官和小鼠模型,发现HGF/MET信号调控肠道稳态、再生及腺瘤形成,且MET的上述作用由干细胞CD44异构体CD44v4-10促进;MET缺失使微腺瘤凋亡增加、数量减少约50%,为结直肠癌抗EGFR治疗中靶向MET/CD44信号提供依据。

要点

  • HGF或EGF均可刺激隐窝形成自组织迷你肠,MET缺失小鼠肠道稳态无缺陷。
  • MET缺失损害辐照后隐窝增殖与ISC再生,并增加微腺瘤凋亡、减少腺瘤数量与大小。
  • HGF促隐窝及腺瘤类器官扩增依赖CD44v4-10,CD44s不能替代。

核心结论

  • HGF受体信号调控肠道稳态、再生及腺瘤形成,这些MET活性由干细胞CD44异构体CD44v4-10促进。
  • 研究结果为结直肠癌患者抗EGFR治疗中或对EGFR抑制剂耐药患者中靶向MET与CD44信号提供依据。

研究设计与样本

  • 建立受HGF或EGF刺激的ISC类器官培养,并用免疫组化评估肠分化。
  • 使用全肠上皮MET破坏小鼠(AhCre/Metfl/fl/LacZ)、ISC特异性MET破坏小鼠(Lgr5Creert2/Metfl/fl/LacZ)及对照小鼠(AhCre/Met+/+/LacZ、Lgr5Creert2/Met+/+/LacZ)接受10 Gy全身照射。
  • 使用Lgr5Creert2/Metfl/fl/Apcfl/fl与Lgr5Creert2/Met+/+/Apcfl/fl小鼠来源腺瘤评估HGF或EGF刺激的腺瘤类器官扩增及腺瘤患病率与大小。
  • 比较AhCre/Metfl/fl/Apcfl/+小鼠与AhCre/Met+/+/Apcfl/+对照小鼠的腺瘤数量。
  • 使用表达不同CD44剪接变体(Cd44+/+、Cd44-/-、Cd44s/s或Cd44v4-10/v4-10)小鼠来源隐窝和腺瘤类器官评估HGF或EGF刺激的扩增。

主要发现

  • EGF或HGF孵育的隐窝扩增为自组织迷你肠,效率相似并含所有分化细胞谱系。
  • MET缺陷小鼠肠道稳态无缺陷;全身照射后AhCre/Metfl/fl/LacZ小鼠增殖隐窝数量减少,Lgr5Creert2/Metfl/fl/LacZ小鼠MET缺陷ISC再生受损。
  • EGF或HGF刺激的腺瘤类器官扩增至未刺激类器官的近两倍大小;MET缺陷腺瘤类器官对HGF刺激无反应,但对EGF有反应。
  • ISC特异性Met破坏(Lgr5Creert2/Metfl/fl/Apcfl/fl小鼠)使微腺瘤凋亡增加两倍,导致微腺瘤数量减少约50%并显著降低平均腺瘤大小;全肠上皮Met破坏(AhCre/Metfl/fl/Apcfl/+小鼠)使(微)腺瘤数量减少约50%。
  • Cd44-/-小鼠肠隐窝经HGF刺激的扩增程度不及Cd44+/+小鼠隐窝,但对EGF反应相同;该负效应可被CD44v4-10表达克服,CD44s不能;HGF介导的腺瘤类器官扩增同样需要CD44v4-10。

临床怎么用

  • 原文结论指出,研究结果为结直肠癌患者抗EGFR治疗中或对EGFR抑制剂耐药患者中靶向MET与CD44信号提供依据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Resistance of metastatic human colorectal cancer cells to drugs that block epidermal growth factor (EGF) receptor signaling could be caused by aberrant activity of other receptor tyrosine kinases, activating overlapping signaling pathways. One of these receptor tyrosine kinases could be MET, the receptor for hepatocyte growth factor (HGF). We investigated how MET signaling, and its interaction with CD44 (a putative MET coreceptor regulated by Wnt signaling and highly expressed by intestinal stem cells [ISCs] and adenomas) affects intestinal homeostasis, regeneration, and adenoma formation in mini-gut organoids and mice. METHODS: We established organoid cultures from ISCs stimulated with HGF or EGF and assessed intestinal differentiation by immunohistochemistry. Mice with total epithelial disruption of MET (AhCre/Metfl/fl/LacZ) or ISC-specific disruption of MET (Lgr5Creert2/Metfl/fl/LacZ) and control mice (AhCre/Met+/+/LacZ, Lgr5Creert2/Met+/+/LacZ) were exposed to 10 Gy total body irradiation; intestinal tissues were collected, and homeostasis and regeneration were assessed by immunohistochemistry. We investigated adenoma organoid expansion stimulated by HGF or EGF using adenomas derived from Lgr5Creert2/Metfl/fl/Apcfl/fl and Lgr5Creert2/Met+/+/Apcfl/fl mice. The same mice were evaluated for adenoma prevalence and size. We also quantified adenomas in AhCre/Metfl/fl/Apcfl/+ mice compared with AhCre/Met+/+/Apcfl/+ control mice. We studied expansion of organoids generated from crypts and adenomas, stimulated by HGF or EGF, that were derived from mice expressing different CD44 splice variants (Cd44+/+, Cd44-/-, Cd44s/s, or Cd44v4-10/v4-10 mice). RESULTS: Crypts incubated with EGF or HGF expanded into self-organizing mini-guts with similar levels of efficacy and contained all differentiated cell lineages. MET-deficient mice did not have defects in intestinal homeostasis. Total body irradiation reduced numbers of proliferating crypts in AhCre/Metfl/fl/LacZ mice. Lgr5Creert2/Metfl/fl/LacZ mice had impaired regeneration of MET-deficient ISCs. Adenoma organoids stimulated with EGF or HGF expanded to almost twice the size of nonstimulated organoids. MET-deficient adenoma organoids did not respond to HGF stimulation, but did respond to EGF. ISC-specific disruption of Met (Lgr5Creert2/Metfl/fl/Apcfl/fl mice) caused a twofold increase in apoptosis in microadenomas, resulting in an approximately 50% reduction of microadenoma numbers and significantly reduced average adenoma size. Total epithelial disruption of Met (AhCre/Metfl/fl/Apcfl/+ mice) resulted in an approximate 50% reduction in (micro)adenoma numbers. Intestinal crypts from Cd44-/- mice did not expand to the same extent as crypts from Cd44+/+ mice on stimulation with HGF, but had the same response to EGF. The negative effect on HGF-mediated growth was overcome by expression of CD44v4-10, but not by CD44s. Similarly, HGF-mediated expansion of adenoma organoids required CD44v4-10. CONCLUSIONS: In studies of intestinal organoid cultures and mice with inducible deletion of MET, we found HGF receptor signaling to regulate intestinal homeostasis and regeneration, as well as adenoma formation. These activities of MET are promoted by the stem cell CD44 isoform CD44v4-10. Our findings provide rationale for targeting signaling via MET and CD44 during anti-EGF receptor therapy of patients with colorectal cancer or in patients resistant to EGF receptor inhibitors.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Joosten SPJ, Zeilstra J, van Andel H, et al. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms. Gastroenterology. 2017. PMID: 28716720. doi:10.1053/j.gastro.2017.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。